News
7h
Medical Device Network on MSNMediView enrols first patient in XR90 study for soft tissue biopsyMediView has announced the first patient enrolment in a multi-centre study to assess the procedural efficiency of its XR90 ...
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can ...
Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...
1don MSN
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require ...
New study by three Indian American researchers promises replacement of invasive surgical biopsies with blood test ...
Recurrent lupus nephritis post-transplant may go undetected without surveillance biopsies. This study reveals high recurrence ...
MediView, a leader in advanced medical imaging technologies, announces the enrollment of the first patient in a clinical ...
The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...
Dear W.D.W.: It is completely understandable to be concerned about a PSA level of 18 ng/mL, but you and your urologist have, ...
Organ transplantation offers life-saving treatment for patients with end-stage organ failure, restoring function and vastly ...
SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, inflammatory and infectious diseases, announced today an independent ...
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results